PRIOR AUTHORIZATION UPDATE FOR PERSERIS AND UZEDY

Date: 01/29/24

Effective March 1, 2024, Perseris and Uzedy are preferred with prior authorization for [Meridian Medicaid Plan] [YouthCare HealthChoice Illinois].

The state of Illinois is also requiring the following to prescribe long-acting injectable antipsychotics (LAIA’s)

·       The prescriber must be a board-certified psychiatrist or a board-eligible psychiatrist. For the purposes of this subsection, a "board-eligible psychiatrist" is a physician who has, within the past 7 years, successfully completed residency training accredited by the Accreditation Council for Graduate Medical Education or approved by the American Board of Psychiatry and Neurology in a psychiatric primary specialty or subspecialty.

• The LAIA drug prior approval will follow the Food and Drug Administration (FDA) approved labeling for the indication for each medication.

• The prescriber agrees to coordinate a follow up outpatient appointment for administration of the next recommended dose of the LAIA agents and provide documentation of the follow up appointment with request for prior approval.

Please refer to the following provider notice for more details.